BioCryst Pharmaceuticals Inc (BCRX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 | 1997-12-31 | 1996-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 940.613 | 874.837 | 450.712 | 331.412 | 270.827 | 157.170 | 17.812 | 48.835 | 20.653 | 25.186 | 26.353 | 48.257 | 13.608 | 17.331 | 26.293 | 19.643 | 63.501 | 74.589 | 56.561,369 | 71.237,901 | 6.211,936 | 151,867 | 336,901 | 1.634 | 1.774,524 | 11.157,634 | 3.315,594 | 2.500 | 6.400 | 1.000 | 2.700 |
Cashflow aus operativer Geschäftstätigkeit | 359.866 | 329.880 | -52.020 | -95.141 | -161.850 | -142.157 | -137.216 | -89.584 | -92.565 | -41.143 | -53.438 | -13.116 | -38.551 | -26.530 | -37.397 | -32.251 | -28.554,221 | -16.218,47 | -20.873,82 | -24.997,799 | -15.211,315 | -23.346,157 | -18.151,335 | -11.196 | -16.364,055 | -10.158,486 | -3.177,64 | -4.900 | -4.200 | -10.300 | -6.800 |
▸ Operative Cashflow Marge | 38,26% | 37,71% | -11,54% | -28,71% | -59,76% | -90,45% | -770,36% | -183,44% | -448,19% | -163,36% | -202,78% | -27,18% | -283,3% | -153,08% | -142,23% | -164,19% | -44,97% | -21,74% | -36,9% | -35,09% | -244,87% | -15.372,76% | -5.387,74% | -685,19% | -922,17% | -91,05% | -95,84% | -196% | -65,62% | -1.030% | -251,85% |
Investitionsausgaben (CapEx) | 2.758 | 2.468 | 1.124 | 2.168 | 1.351 | 2.385 | 514 | 343 | 366 | 328 | 5.277 | 5.122 | 106 | 30 | 113 | 55 | 324,764 | 603,692 | 1.212,274 | 3.343.827 | 1.534,686 | 497,284 | 275,919 | 52 | 407,88 | 2.604,379 | 2.723,296 | 1.000 | 400 | 1.100 | 300 |
Cashflow aus Investitionstätigkeit | -448.712 | -13.694 | 52.593 | -131.498 | -128.238 | 15.804 | -6.856 | 77.934 | 4.768 | -66.382 | 23.339 | -18.004 | -39.980 | -3.467 | 24.884 | 11.318 | 221,068 | -12.894,416 | 11.393,919 | -15.033,356 | -12.489,208 | -11.514,058 | -2.836,967 | 8.413 | 11.200,437 | 20.382,058 | 1.463,574 | -47.700 | 5.800 | 10.200 | -27.200 |
Cashflow aus Finanzierungstätigkeit | 140.894 | -332.442 | -5.761 | 32.485 | 88.027 | 359.668 | 302.697 | 99.098 | 62.504 | 135.703 | 23.304 | 5.479 | 111.907 | 30.270 | 16.960 | 23.755 | 830,586 | 47.895,765 | 666,639 | 66.768,947 | 2.961,224 | 55.178,578 | 21.478,763 | 900 | 122,581 | 185,952 | 1.538,421 | 49.000 | 6.900 | 200 | 31.500 |
Freier Cashflow | 357.108 | 327.412 | -53.144 | -97.309 | -163.201 | -144.542 | -137.730 | -89.927 | -92.931 | -41.471 | -58.715 | -18.238 | -38.657 | -26.560 | -37.510 | -32.306 | -28.878,985 | -16.822,162 | -22.086,094 | -3.368.824,799 | -16.746,001 | -23.843,441 | -18.427,254 | -11.248 | -16.771,935 | -12.762,865 | -5.900,936 | -5.900 | -4.600 | -11.400 | -7.100 |
▸ Freie Cashflow Marge | 37,97% | 37,43% | -11,79% | -29,36% | -60,26% | -91,97% | -773,24% | -184,14% | -449,96% | -164,66% | -222,8% | -37,79% | -284,08% | -153,25% | -142,66% | -164,47% | -45,48% | -22,55% | -39,05% | -4.728,98% | -269,58% | -15.700,21% | -5.469,63% | -688,37% | -945,15% | -114,39% | -177,98% | -236% | -71,87% | -1.140% | -262,96% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | - | - | - | - | - | 65.794 | 110.542 | 79.621 | 56.252 | 135.581 | 317 | 5.479 | 111.907 | 25.090 | 18.660 | -61 | -5,011 | -155,505 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.